Nevertheless, while targeted disruption of NFAT1 or NFAT2 genes separately did not prevent T cell activation and IL-2 production, expression of a dominant negative NFAT in T cells did [4], suggesting that complete elimination of NFAT activity may prevent tumor control in vivo, although this has not been tested directly. This evidence concerns the gene NFATC2 and neoplasm.